早新闻｜重磅来袭，就在今日！

Group 1: Macroeconomic Highlights - The State Council Information Office will hold a press conference on September 22, 2025, to discuss the achievements of the financial industry during the "14th Five-Year Plan" period, featuring key officials from the People's Bank of China and financial regulatory bodies [1] - The People's Bank of China will announce the new Loan Market Quote Rate (LPR) on September 22, with the previous rates remaining unchanged at 3.0% for 1-year and 3.5% for 5-year and above for three consecutive months [1] - The central bank has adjusted the 14-day reverse repurchase operation method to a fixed quantity, interest rate bidding, and multiple price bidding to better meet the liquidity needs of different institutions [1] Group 2: Company News - SF Holding reported a revenue of 24.787 billion yuan from its express logistics business in August, marking a year-on-year increase of 7.86% [7] - Chengyi Pharmaceutical's controlling shareholder plans to reduce its stake by no more than 1.18% [7] - Helin Micro-Nano's controlling shareholder has decided to terminate its share reduction plan early [7] - Shenli Co., Ltd. plans to reduce its stake by no more than 3% [7] - Jinfatech's shareholder intends to reduce its stake by no more than 1% [7] - Zhongzhong Technology's shareholder plans to reduce its stake by no more than 3% [7] - Ruijun Power's controlling shareholder and its concerted actors plan to reduce their stake by no more than 2% [7] - Shunhao Co. plans to repurchase shares worth 100 million to 200 million yuan [7] - Ankai Micro plans to invest 20 million yuan to acquire 4% of Zhiqi Future [7] - Baoli International intends to invest in semiconductor testing equipment company Hongtai Technology, acquiring 1%-3% equity [7] - Jintou City Development plans to adjust its major asset restructuring plan to a "major asset sale plan" [7] - Western Materials' subsidiary is planning a major asset restructuring, leading to a stock suspension [7] - Pinming Technology is expected to remain suspended from trading beyond September 22 [7] - Shenzhen Securities Regulatory Bureau has issued a warning letter to Yuanzhi Technology's controlling shareholder [7] - Watson Bio's clinical trial application for a freeze-dried herpes zoster virus mRNA vaccine has been accepted [7] - ST New Power is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [7] - Juewei Food and Fudan Fuhua will face risk warnings and be suspended from trading for one day starting September 22 [7]